Digital Musculoskeletal Care Market: Comparative Analysis of Transatlantic Champions vs. European Platform Innovations

The global market for digital musculoskeletal (MSK) care and digital therapeutics (DTx) is undergoing a structural transformation, transitioning from simple virtual physical therapy to comprehensive, AI-enabled, pathway integrated patient self management platforms. Valued at $4.4 billion in 2024, the global digital MSK care market expanded to approximately $5.1 billion to $6.0 billion between 2025 and 2026. 
  
Industry projections indicate a compound annual growth rate (CAGR) of 17.7% to 17.8%, driving the sector toward $11.6 billion by 2030 and reaching $18.96 billion by 2033. Within this ecosystem, the subset of artificial intelligence (AI)-powered chronic pain coaching is growing at a CAGR of 22.7%, expanding from $1.68 billion in 2025 to $2.06 billion in 2026, and forecast to reach $4.61 billion by 2030.

Musculoskeletal conditions represent one of the most substantial financial and operational burdens placed upon global healthcare systems and national economies. In the United Kingdom alone, over 20 million people suffer from an MSK condition, generating between 18% and 30% of all general practitioner (GP) consultations and costing the National Health Service (NHS) approximately £5 billion annually. 
  
Up to 20% of this healthcare expenditure is attributed to over treatment, unnecessary secondary care referrals, and redundant diagnostic imaging. Beyond direct healthcare costs, MSK complaints account for over half of all employee sickness absences, inflicting a £7 billion annual loss on the UK economy through reduced workplace productivity and lost workdays.
  
This macroeconomic burden has triggered a shift in how payers, employers and public health systems evaluate digital health technologies. Historical digital health deployments favoured capital-intensive, high-friction models reliant on hardware peripheral distribution (such as external motion sensors and specialised tablets) paired with high-cost 1:1 human tele-coaching. 
  
However, regional variations in healthcare delivery systems have caused a clear market split:
  
North American Enterprise Models: Characterised by companies like Hinge Health and Sword Health, these models rely on self-insured employer benefit budgets, direct-to-enterprise sales forces, high per-member-per-month (PMPM) or engagement-based pricing, and hardware-assisted movement tracking.

European Single-Payer and Hardware-Light Platforms: Exemplified by platforms such as getUBetter, EQL Phio, and Flok Health, these solutions integrate directly into public care pathways (e.g., NHS Integrated Care Systems). These platforms prioritise hardware-light, population-wide software deployment, automated digital triage, and evidence-based patient self-management.
  
This regional split highlights a major market opportunity. While North American vendors face high customer acquisition costs and enterprise budget saturation, the European market represents a largely untapped, single-payer landscape. Digital therapeutics that successfully secure regulatory clearance (CE mark), clinical validation (NICE recommendations), and local electronic health record (EHR) integration can achieve population-wide adoption at a fraction of the per-capita acquisition cost seen in the US.

Click here to read the report in full https://www.healthcare.digital/single-post/digital-musculoskeletal-care-market-transatlantic-champions-v-european-platform-innovations